David Hall

Statistics

Publications

Citations

264

H-Index

Active since

2015

Affiliations

Rockefeller University(Current)

David Hall is an author at Rockefeller University specializing in placebo-controlled efficacy assessment, interleukin 23 inhibition, and immunotherapy.

Publications per year

2015–2016

Publications

Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial

James G. Krueger, Laura K. Ferris, Alan Menter et al. · Journal of Allergy and Clinical Immunology · 2015 · 250 citations

Medicine, Immunology, Pharmacology +15

812a Efficacy and Safety of Induction Therapy With the Selective IL-23 Inhibitor BI 655066, in Patients With Moderate-to-Severe Crohn's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Brian G. Feagan, William J. Sandborn, Julián Panés et al. · Gastroenterology · 2016 · 14 citations

Pharmacy, Immunology, Pharmacotherapy +16

1–2 of 2